loadpatents
name:-0.0088858604431152
name:-0.0138099193573
name:-0.00049781799316406
DeBernardis; John F. Patent Filings

DeBernardis; John F.

Patent Applications and Registrations

Patent applications and USPTO patent grants for DeBernardis; John F..The latest application filed is for "method of detecting tau protein and tau fragments in serum".

Company Profile
0.13.8
  • DeBernardis; John F. - Lake Zurich IL
  • DeBernardis; John F. - Lindenhurst IL
  • DeBernardis; John F. - Lake Villa IL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Method Of Detecting Tau Protein And Tau Fragments In Serum
App 20130095492 - DeBernardis; John F. ;   et al.
2013-04-18
Method for Predicting Whether Subjects With Mild Cognitive Impairment (MCI) Will Develop Alzheimer's Disease
App 20090022825 - Kerkman; Daniel ;   et al.
2009-01-22
Purified Antigen for Alzheimer's Disease and Methods of Obtaining and Using Same
App 20080181883 - Zinkowski; Raymond P. ;   et al.
2008-07-31
Purified antigen for Alzheimer's disease and methods of obtaining and using same
App 20050272094 - Zinkowski, Raymond P. ;   et al.
2005-12-08
Purified antigen for Alzheimer's disease and methods of obtaining and using same
Grant 6,864,062 - Zinkowski , et al. March 8, 2
2005-03-08
Method for predicting whether subjects with mild cognitive impairment (MCI) will develop Alzheimer's Disease
App 20040166536 - Kerkman, Daniel ;   et al.
2004-08-26
Purified antigen for Alzheimer's disease and methods of obtaining and using same
App 20030113896 - Zinkowski, Raymond P. ;   et al.
2003-06-19
Purified Antigen For Alzheimer's Disease, And Methods Of Obtaining And Using Same
App 20020002270 - ZINKOWSKI, RAYMOND P. ;   et al.
2002-01-03
Angiotensin II receptor antagonists
Grant 5,326,776 - Winn , et al. July 5, 1
1994-07-05
Tertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitors
Grant 5,288,749 - Meyer , et al. February 22, 1
1994-02-22
Angiotensin II receptor antagonists
Grant 5,250,548 - Winn , et al. October 5, 1
1993-10-05
5-HT selective agents
Grant 5,244,888 - DeBernardis , et al. September 14, 1
1993-09-14
1-aminomethyl-1,2,3,4-tetrahydronaphthalenes
Grant 5,140,040 - DeBernardis , et al. August 18, 1
1992-08-18
5-HT selective agents
Grant 5,049,564 - DeBernardis , et al. September 17, 1
1991-09-17
Dopamine agonists
Grant 4,963,568 - Schoenleber , et al. October 16, 1
1990-10-16
1,2,3,3a,8,8a-hexahydro-indeno[1,2-c]pyrroles useful in the treatment of hypertension
Grant 4,622,405 - DeBernardis , et al. November 11, 1
1986-11-11
Tetrahydro-6,7-dimethoxy-1H-benz[e]isoinodolines useful in the treatment of hypertension and as sedatives
Grant 4,618,683 - DeBernardis , et al. October 21, 1
1986-10-21
Substituted 1-aminomethyl-phthalans
Grant 4,500,543 - Debernardis , et al. February 19, 1
1985-02-19
Aminoalkyl dihydronaphthalenes
Grant 4,473,586 - Debernardis , et al. September 25, 1
1984-09-25
2-(4-Phenylalkanoylpiperazin-1-yl) quinazoline compounds, pharmaceutical compositions and method of producing .alpha..sub.1 antagonistic activity
Grant 4,440,769 - DeBernardis , et al. April 3, 1
1984-04-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed